CD30 ligand (CD30L, CD153), a member of the tumor necrosis factor (TNF) superfamily, and its receptor CD30 are important for differentiation and activation of CD4 þ T helper type 17 (Th17) cells. In this report, we demonstrate that the interleukin 17A (IL-17A)-producing cd T cells normally developed in the fetal thymus, whereas Vc1 À Vc4 À cd T cells expressed Vc6/Vd1 gene transcript selectively decreased in mucosa-associated tissues in naive CD30KO or CD30LKO mice. Moreover, CD30 and CD30L were expressed preferentially by Vc1 À Vc4 À cd T cells in naive mice. The bacteria clearance was attenuated by the impaired response of the IL-17A-producing cd T cells and decreased infiltration of neutrophils in CD30KO or CD30LKO mice. In vivo administration of agonistic anti-CD30 monoclonal antibody restored the ability of protection against Listeria monocytogenes by enhancing Vc1 À Vc4 À cd Tcells producing IL-17A not only in wild-type but also CD30LKO mice. Taken together, it appears that CD30L/CD30 signaling plays an important role in the maintenance and activation of IL-17A-producing cd T cells presumably bearing Vc6 in the mucosa-associated tissues of mice.
INTRODUCTION
The gd T cells are the first lymphocytes to develop in the thymus. The gd T cells expressing Vg5, Vg6, and Vg4 (T cell receptor (TCR) nomenclature by Dr S. Tonegawa) 1 sequentially develop in this order in the fetal thymus from approximately embryonic day 12 (ED12) and migrate into mucosal epithelia such as skin, intestine, uterus, and lung as tissue-associated cells. [1] [2] [3] Unlike conventional T cells, which are exported from the thymus as naive cells and acquire effector functions upon antigen encounter in the periphery, many murine gd T cells are functionally committed into effector cells producing cytokines within the fetal thymus and are disproportionately distributed in mucosal epithelia. 1, [4] [5] [6] [7] [8] We have previously reported that freshly isolated gd T cells from fetal thymus produce interleukin 17A (IL-17A) in response to phorbol myristate acetate (PMA) and ionomycin stimulation and the number of such IL-17A-producing gd T cells in the thymus peaks at the perinatal period and gradually decreases with age. 9 In the periphery, Vg6 þ IL-17A-producing gd T cells were predominantly detected in the peritoneal cavity, lamina propria of the gut, and female reproductive organs (reproductive intraepithelial lymphocytes). 9 In marked contrast, no Vg5 þ gd T cells in the skin (skin intraepithelial lymphocytes) or Vg7 þ gd T cells in the intestinal intraepithelial lymphocytes produced IL-17A. Thus, there is a difference in the frequency of IL-17A-producing cells in gd T cells depending on the TCR V repertoire and anatomical location in the periphery.
Several members of the tumor necrosis factor (TNF) receptor superfamily (TNFRSF) and TNF superfamily (TNFSF) have been shown to regulate the fate of T cells, including ab T cells and gd T cells. [10] [11] [12] Members of the TNFR superfamily such as Fas and TNFRI, which contain a death domain in the cytoplasmic tail, are responsible for activation-induced T-cell death, whereas those having no death domain such as CD40 and CD70 play a key role in effective T-cell immunity. associated glycoprotein belonging to the TNFSF 10, 11 and is expressed on activated and memory CD4 þ T helper (Th) cells. It should be noted that there are several lines of evidence for expression in macrophages, dendritic cells, B cells, and unique CD4 þ CD3 À CD11c À accessory cells, which are the adult equivalent of inducer cells for the development of lymph node and Peyer's patch in ontogeny. [13] [14] [15] CD30, the receptor for CD30L, and belonging to the TNFRSF, was reported to be preferentially expressed by activated/memory Th cells but not by resting B or T cells. 10, 11 CD30L/CD30 signaling is thought to be involved in Th2 cell responses and Th2-associated diseases. [16] [17] [18] However, a number of recent studies suggest that CD30L/CD30 signaling is also linked to Th1 cell responses and Th1-associated diseases. [19] [20] [21] Furthermore, there are several lines of evidence in which naturally occurring regulatory T cells suppressed allograft rejection mediated by memory CD4 þ T cells via a CD30-dependent mechanism. 22, 23 We recently found that CD30L/CD30 signaling executed by T/T cell interaction plays a critical role in Th1 and Th17 cell differentiation in vitro and in vivo. [24] [25] [26] Thus, CD30L/CD30 signaling might not be directly linked to a physiological step for the differentiation of a specific Th cell subset but might be important for amplification and/or activation of effector and/or memory Th cells.
We show here that naturally occurring IL-17A-producing gd T cells normally develop in the fetal thymus in CD30LKO or CD30KO mice, whereas Vg1 À Vg4 À gd T cells expressing Vg6/Vd1 gene transcript are selectively reduced in the mucosaassociated tissues of adult CD30LKO or CD30KO mice. The numbers of bacteria were significantly larger in the peritoneal cavity at the early stage of Listeria monocytogenes infection accompanied by reduced infiltration of neutrophils and gd T cells producing IL-17A. Taken together, it appears that CD30L/ CD30 signaling plays an important role in the maintenance and activation of a subset of naturally occurring IL-17A-producing gd T cells in mucosa-associated tissues.
RESULTS

CD30L/CD30 signaling is not required for intrathymic differentiation of cd T cells
Recently, it has been shown that gd T cells could be generated and differentiated within the fetal thymus into unconventional IL-17A-or interferon-g (IFN-g)-producing effector gd T cells, which are considered as naturally occurring gd T cells. [6] [7] [8] [9] Therefore, we first examined the role of CD30L/CD30 signaling in intrathymic differentiation of naturally occurring gd T cells, using CD30LKO or CD30KO mice. Thymocytes were isolated from the fetal thymus of CD30LKO, CD30KO, or wild-type (WT) mice on ED19. As shown in Supplementary Figure S1a  and Figure S1c online ). Upon stimulation with PMA/inonomycin, intracellular cytokine fluorescence-activated cell sorting (FACS) analysis revealed no differences in the proportion of naturally occurring gd T cells capable of producing IFN-g or IL-17A in the fetal thymus between WT mice and CD30KO or CD30LKO mice. There were no differences in the Vg repertoires of IL-17A-or IFN-g-producing gd T-cell subsets in the fetal thymus between CD30KO or CD30LKO mice and WT mice (Supplementary Figure S1d and e online). We also found no difference in the number of gd T cells producing IL-17A or IFN-g in the adult thymus (Supplementary Figure  S2 online ). Therefore, these results suggest that CD30L/CD30 signaling is not necessary for intrathymic differentiation of naturally occurring gd T cells.
CD30L/CD30 signaling selectively contributes to maintenance of Vc1 À Vc4 À cd T cells in mucosa-associated tissues of naive mice It has been reported that gd T cells are exported from the fetal thymus as effector gd T cells and maintained in peripheral tissues such as the uterus, intestine, or peritoneal cavity of naive mice.
9,27-31 Therefore, we investigated the role of CD30L/CD30 signaling in the maintenance of gd T cells in peripheral tissues. There was no difference in the number of gd T cells in these peripheral tissues, such as peritoneal exudate cells (PECs), lamina propria lymphocytes (LPLs), uterus, liver, lung, and spleen between CD30KO or CD30LKO mice and WT mice ( Figure 1a) . The Vg repertoire analysis of gd T-cell subsets in these peripheral tissues was examined by a flow cytometer with available mAbs against Vg1 and Vg4. It was found that the major gd T cell subset consisted of Vg1 À Vg4 À subsets in PECs, LPLs, and uterus. Furthermore, the frequency and absolute number of Vg1 À Vg4 À gd T-cell subsets significantly decreased in only these tissues, but not in spleen, liver, and lung of CD30KO and CD30LKO mice relative to WT mice ( Figure 1b and Supplementary Figure S3a online) . In contrast, the frequency but not the cell number of the Vg1 þ or Vg4 þ gd T-cell subset was relatively higher in PECs, LPLs, or uterus of CD30KO or CD30LKO mice than that in WT mice (Figure 1b) . To identify the Vg repertoire of Vg1 À Vg4 À gd T-cell subsets, we examined the TCR V repertoire of gd T cells in PECs and LPLs from WT mice by reverse transcriptase-PCR analysis, because mAbs against Vg6 were not available. As shown in Figure 1c , the Vg repertoires of gd T cells in LPLs as well as PECs consist mainly of Vg1, Vg2, Vg4, and Vg6, but no expression of Vg5 or Vg7 was detected, which is consistent with our previous report in which Vg6 was preferentially expressed by gd T cells in PECs. 32 To further identify the repertoire of Vg1 À Vg4 À subset of gd T cells, Vg1 À Vg4 À gd T cells were sorted from PECs and determined by reverse transcriptase-PCR. We found that Vg1 As Vg2 transcript is often coexpressed with other Vg transcripts, and Vd1 chain is known to pair mainly with Vg5 or Vg6, 5, 6 this result strongly suggests that Vg1 À Vg4 À gd T cells expressed Vg6 chain paired with Vd1 chain. Next, we found that the mRNA expression levels of Vd1 and Vg6 decreased markedly in gd T cells of PECs from CD30KO or CD30LKO mice when compared with those in WT mice ( Figure 1d ). Therefore, we speculate that CD30L/CD30 interactions may contribute to the maintenance of Vg1 À Vg4 À gd T cells in mucosa-associated tissues such as PECs, LPLs, and uterus in naive mice.
CD30L/CD30 signaling is necessary for maintenance of naturally occurring IL-17A-producing Vc1
cells in mucosa-associated tissues
We recently demonstrated that naturally occurring gd T cells are exported from the thymus as effector gd T cells and maintained in several peripheral tissues, and that these effector gd T cells have the ability to produce IL-17A without antigen stimulation. 9, 33 We examined the ability of gd T cells to produce IL-17A or IFN-g in PECs, LPLs, and uterus of CD30KO or CD30LKO mice after culture for 5 h with or without PMA/ ionomycin stimulation. As shown in Figure 2a , except for We next analyzed the repertoire of IL-17A-producing gd T cells in mucosal-associated tissues. As shown in Figure 2b , IL-17A was mainly expressed by Vg1 À Vg4 À presumably bearing Vg6 gd T cells in PECs, LPLs, and uterus of naive WT mice in the presence or absence of PMA/ionomycin stimulation, because Vg1 þ gd T cells only produced IFN-g but not IL-17A (data not shown). Compared with WT mice, the frequency and cell number of IL-17A þ Vg1 À Vg4 À gd T cells in PECs and LPLs of naive CD30KO or CD30LKO mice significantly decreased (Figure 2b ). There was no significant difference in the percentage of IL-17A þ Vg4 þ gd T cells in gd T cells between WT and CD30KO or CD30LKO mice, yet the number of IL-17A þ Vg4 þ gd T cells was relatively higher only in PECs of CD30KO or CD30LKO mice under PMA/ionomycin stimulation than in WT mice (Figure 2b) . These results proved that CD30L/CD30 signaling could specifically expedite the maintenance of the IL-17A-producing Vg1 À Vg4 À gd T-cell subset in these mucosa-associated tissues such as PECs, LPLs, and uterus of naive mice. inoculation with 5 Â 10 5 CFU L. monocytogenes. On days 1, 3, and 5 after infection, the numbers of bacteria in PECs in CD30KO or CD30LKO mice were markedly larger than those in WT mice (Figure 4a) . The number of total PECs that increased after infection in WT mice was similar to that of CD30KO or CD30LKO mice (Figure 4b) . However, comparing with WT mice, the number of gd T cells decreased significantly in CD30KO or CD30LKO mice on days 1, 3, and 5 after infection (Figure 4b) . On day 5 after infection, the frequency of Vg1 À Vg4 À gd T cell in PECs of CD30KO or CD30LKO mice was much lower than that in WT mice (Figure 4c) . (Figure 4d) .
The absolute number of CD11b þ Gr-1 hi F4/80 À neutrophils was lower in PECs of CD30KO or CD30LKO mice than that of WT mice on days 1, 3, and 5 after infection (Figure 5a ). Spontaneous cytokine production was measured after infection. The level of IL-17A, but not of IL-23 or IL-12p70, significantly decreased in CD30KO or CD30LKO mice as compared with those in WT mice on days 1, 3, and 5 after infection ( Figure 5b) . As shown in Figure 5c , gd T cells could spontaneously produce IL-17A but hardly produce IFN-g. Furthermore, the frequency and absolute number of gd T cells producing IL-17A, but not IFN-g, significantly decreased in CD30KO or CD30LKO mice on days 1, 3, and 5 after infection compared with those in WT mice (Figure 5c and Supplementary Figure S6 online) . In accordance with a previous report, 35 the Vg1 þ subset of the gd T cells hardly produced IL-17A, whereas compared with the Vg4 þ subset, the Vg1 À Vg4 À subset of the gd T cells were the principal source of IL-17A during the early stage of Listeria infection (Figure 5d) . Furthermore, the percentage and absolute number of IL-17A producing this subset of gd T cells decreased significantly in CD30KO or CD30LKO mice on the days indicated as compared with those in WT mice (Figure 5d ).
To determine whether CD30 signaling via CD30L is involved in early protection against L. monocytogenes infection, we next examined the effect of agonistic anti-CD30 mAb on bacterial growth and on gd T cell producing IL-17A after 1 Â 10 6 CFU of L. monocytogenes infection. As shown in Figure 5e , the Vg1 À Vg4 À subset of the gd T cells that produced IL-17A increased significantly and bacterial clearance ability was restored by treatment of agonistic anti-CD30 mAb on day 3 after infection not only in WT mice but also in CD30LKO mice. Therefore, these data strongly demonstrate that CD30L/CD30 interactions selectively contribute to maintenance of the Vg1 À Vg4 À subset of gd T cells, which is the main source of IL-17A during the early stage of protection against L. monocytogenes infection.
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DISCUSSION
We show here that CD30L/CD30 signaling plays an important role in maintenance of the naturally occurring IL-17A-producing gd T cells presumably bearing Vg6 in the mucosa-associated tissues such as PECs, LPLs, and uterus in naive mice. Furthermore, CD30L/CD30 interactions contributed to IL-17A-producing gd T cell subset-mediated early protection against L. monocytogenes infection in mice.
There are several possibilities to explain why the maintenance of the Vg1 À Vg4 À subset of naturally occurring gd T cells producing IL-17A is dependent on CD30L/CD30 signaling in naive mice. The gd T cell bearing Vg6 is functionally committed into the effector cell producing IL-17A within the fetal thymus, raising the first possibility that CD30L/CD30 signaling is required for the development of naturally occurring IL-17A-producing gd T cells in the fetal thymus. However, the gd T cells producing IL-17A normally developed in the fetal thymus of CD30KO or CD30LKO mice, suggesting that CD30L/CD30 signaling is not essential in the development of gd T cells in the fetal thymus. Second, we previously reported that gene expression of CCR7 (C-C chemokine receptor type 7), which is preferentially expressed by naive T cells and central memory T cells, was upregulated by CD30 signaling stimulation in the human YT lymphoma cell line and murine T cells. 36, 37 Furthermore, expression of CCL21 (chemokine (C-C motif) ligand 21), a ligand for CCR7, was reported to be upregulated by CD30L/CD30 signaling in the absence of lymphotoxin-a. 38 Taken together, this suggests that CD30L/ CD30 signaling recruits the gd T-cell subsets from the thymus to the periphery via expression of chemokine receptors on gd T cells. However, secondary lymphoid tissues such as spleen and lymph node expressed CCL21, recruiting CCR7 þ naive T cells or central memory T cells, 39, 40 whereas mucosa-associated tissues, such as LPLs and peritoneal cavity, preferentially express CCL20 recruiting CCR6 þ effector T cells. 41 It is possible that CD30L/CD30 interactions selectively enhance chemokine receptor CCR6 expression in IL-17A-producing Vg1 À Vg4 À bearing Vg6 gd T cells in PECs and promote the homing of this subset of gd T cells producing IL-17A. However, IL-17A-producing Vg4 þ gd T cells were reported to also express CCR6, 42 excluding this possibility. Third, it has been reported that gd T cells secrete IL-17A in response to IL-23 and IL-1b without TCR activation and without the requirement for antigen-presenting cell (APC). 31, 33, 43 Therefore, it is also possible that the gd T cells may be impaired in response to exogenous IL-23/IL-1b in the absence of CD30L/CD30 signaling. To determine this, we examined the effect of IL-23 or IL-1b on IL-17A-producing gd T cells from WT, CD30KO, and CD30LKO mice and found that IL-23, but not IL-1b, enhanced IL-17A production by gd T cells with the same degree, regardless of deficiency of CD30L/CD30 signaling (data not shown). However, the frequency of IL-17A þ gd T cells remained at significantly lower level in CD30KO or CD30LKO mice than those in WT mice. These results suggest that IL-23 induces IL-17A production by gd T cells independently of CD30L/CD30 signaling, but does not overcome the defect in CD30L/CD30. Fourth, CD30 has the potency to induce TRAF-2 (TNF receptor-associated factor 2)-mediated nuclear factorkB activation, can recruit TRAF-1, and can possibly also contribute to increased T-cell survival. 44, 45 Thus, it is possible that CD30L/CD30 signaling may promote cell survival of gd T cells for maintenance in naive mice and increase in infected mice. CD30L and CD30 were reported to be preferentially expressed by activated/memory Th cells but not by resting T cells. 10, 11, [13] [14] [15] A number of recent studies suggested that CD30L/CD30 signaling is also linked to memory Th cell responses and their associated diseases, irrespective of the Th subset. [16] [17] [18] [19] [20] [21] CD30L/CD30 signaling may also be important for amplification of already differentiated effector or memory T cells including naturally occurring gd T cells.
An important finding in this study is that only Vg1 À Vg4
À gd T cells in freshly isolated PECs or LPLs of naive WT mice expressed CD30 and CD30L, and their expressions increased after culture in medium alone. We have recently found the importance of HES1 (hairy and enhancer of split-1) induced by Notch-ligand interaction in the acquisition and maintenance of the IL-17A-producing function of gd T cells. 46 Vg6 þ gd T cells in PECs express Notch1 and have the ability to produce IL-17A. 9, 46 Notch signaling was reported to induce IL-7Ra in T-lineage cells and IL-7 was reported to induce CD30L on innate lymphoid cells. 47, 48 Therefore, the Notch/IL-7Ra axis may be involved in the expression of CD30L/CD30 on the gd T cells. On the other hand, stimulation with anti-CD3 mAb induced CD30 or CD30L on all Vg repertoires of gd T cells, not only in PECs or LPLs but also in spleen or lymph nodes (data not shown). These results suggest that Vg1 À Vg4 À gd T cells may be stimulated upon TCR by recognizing an unknown antigen in the medium or in autoantigens expressed by neighboring gd T cells. The Vg6/Vd1 gd T cells bear invariant TCRs, even to the nucleotides in the TCR gene junction. 2, 49, 50 The canonical sequence is very simple, with no apparent N-region contribution. 3 Such a characteristic has led to the hypothesis that this subset of gd T cells represents a preprogram to recognize a limited set of self-antigens induced by stress or environmental antigens derived from commensal microflora. At present, the specificity of the gd T cells remains unknown. Therefore, it is of interest to ascertain whether the murine Vg6 gd T cells recognize such unique antigens in a manner different from that of other Vg repertoires of gd T-cell subsets.
The IL-17A-producing gd T cells are known to play a protective role at the early stage after L. monocytogenes. 35 In this study, we found that the number of IL-17A-producing Vg1
À
Vg4
À gd T cells increased in the peritoneal cavity of WT mice but not in CD30LKO or CD30KO mice at the early stage after intraperitoneal infection with L. monocytogenes. It appears that CD30L/CD30 signaling plays an important role in early protection against L. monocytogenes infection at least by enhancing IL-17A production by gd T cells. We have previously reported that IL-17A-producing Vg1 À Vg4 À gd T cells bearing Vg6 selectively increased after intraperitoneal infection in response to cytokines such as IL-23 in a bystander manner. 32 As basal levels of naturally occurring IL-17A-producing Vg1 À Vg4 À gd T cells were significantly lower in the peritoneal cavity of naive CD30L or CD30KO mice, the number of naturally occurring IL-17A-producing gd T cells remained at the lower level in the peritoneal cavity of these mice after infection, resulting in an impaired protection against L. monocytogenes infection. It is also possible that de novo synthesis of CD30L and CD30 after infection contributes to activation of IL-17A-producing gd T cells. Further experiments need to clarify these possibilities.
In conclusion, CD30L/CD30 signaling plays an important role in the maintenance of the naturally occurring IL-17A-producing gd T cells presumably bearing Vg6 in the mucosa-associated tissues of naive mice. In addition, CD30L/CD30 interactions contribute to IL-17A-producing Vg1 À Vg4 À gd T cell-mediated innate immunity against bacterial infection.
METHODS
Mice. Age-and sex-matched C57BL/6 (B6) male mice were purchased from Japan KBT (Shizuoka, Japan). The generation and preliminary characterization of CD30LKO (BALB/c background) mice has been described previously, 51 and eight or more generations were backcrossed onto B6 mice. CD30KO (B6.129P2-Tnfrsf8(tm1Mak)/J) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). All mice were maintained under specific pathogen-free conditions and were offered food and water ad libitum. All mice were used at 6-8 weeks of age. This study was approved by the Committee of Ethics on Animal Experiments in the Faculty of Medicine, Kyushu University (Fukuoka, Japan). Experiments were performed under the control of the Guidelines for Animal Experiments.
Microorganisms. L. monocytogenes, strain EGD, was used in all experiments. Bacterial virulence was maintained by serial passages in B6 mice. Fresh isolates were obtained from infected spleens, grown in tryptic soy broth (Nissui Pharmaceutical, Tokyo, Japan), washed repeatedly, resuspended in phosphate-buffered saline, and stored at À 70 1C in small aliquots.
Bacterial growth. Mice were inoculated intraperitoneally with viable L. monocytogenes in 0.2 ml of phosphate-buffered saline on day 0 at a sublethal dose of 5 Â 10 5 CFU, which corresponds to one-tenth of the LD 50 (lethal dose, 50%) for C57BL/6 mice. On days 1, 3, and 5 after infection, the mice were killed, and PECs were irrigated with 4 ml of ice-cold Hank's balanced salt solution and harvested after gentle massage. Samples were spread on trypto-soya agar plates, and colonies were counted after incubation for 24 h at 37 1C.
Abs and reagents. Fcg receptor-blocking mAb (CD16/32; 2.4G2), Alexa Fluor 488, and Alexa Fluor 647 anti-IL-17A (TC11-18H10) were purchased from BD Biosciences (San Diego, CA). Fluorescein isothiocyanate (FITC)-conjugated anti-TCRgd (GL3), PerCP-eFluor 710 anti-TCRgd (eBioGL3), phycoerythrin (PE)-conjugated anti-CD30 (mCD30.1), anti-CD153 (RM153), APC-conjugated anti-TCRab (GL3), and PerCP-eFluor710 anti-MCH class II (M5/114.15.2) were purchased from e-Bioscience (San Diego, CA). APC-conjugated antiTCRgd (GL3), FITC-conjugated and PE-conjugated anti-Vg1.1 (2.11), and anti-TCR Vg2 (UC3-10A6) were purchased from BioLegend (San Diego, CA). PE-and FITC-anti-CD3e (145-2C11), FITC-anti-Vg3 TCR (536), PE-anti-IL-17A (TC11-8H10), and APC-anti-IFN-g (XMG1.2) were purchased from BD Pharmingen (San Diego, CA). Armenian hamster IgG (eBio299Arm) was purchased from Wako Pure Chemicals (Osaka, Japan). Purified anti-CD3 was obtained from e-Bioscience.
Cell preparation. Single cells were isolated from fetal thymus, adult thymus, splenocytes, PECs, LPLs, liver, lung, and uterus, as previously described. 9 Flow cytometric analysis and intracellular cytokine staining.
Isolated cells from various tissues of naive mice were incubated with an Fcg receptor-blocking mAb to prevent nonspecific staining. After washing, cells were stained with various combinations of mAbs. Stained cells were washed twice and resuspended, and propidium iodide (1 mg ml À 1 ) was added before running on a FACSCalibur flow cytometer (BD Biosciences) to detect and exclude dead cells for the analysis of surface staining. For intracellular cytokine staining, cells were stimulated with 25 ng ml À 1 of PMA (P-8139, Sigma-Aldrich, Tokyo, Japan) and 1 mg ml À 1 of ionomycin (I-0634, Sigma-Aldrich) for 5 h at 37 1C, and 10 mg ml À 1 of brefeldin A was added for the last 4 h of culture. In some experiments, cells were co-cultured with IL-23 (20 ng ml À 1 ) and/or IL-1b (20 ng ml À 1 ) for 7 h, and brefeldin A was added at the last 5 h. After culture, cells were harvested and surface stained with various mAbs for 30 min at 4 1C, and then intracellular staining was performed according to the manufacturer's instructions (BD Biosciences). The data were analyzed by FlowJo software (BD Biosciences). 0 -TGGAATCCTGTGGACTCCATGAAAC-3 0 . PCR was performed on a PCR thermal cycler (Takara, Otsu, Shiga, Japan).
Cytokine enzyme-linked immunosorbent assay. On day 5 after L. monocytogenes infection, PECs from L. monocytogenes-infected mice were harvested and cultured without any stimulation for 24 h at 37 1C in a 96-well-plate. The levels of IL-23, IL-17A, and IL-12p70 in the supernatants were measured by DuoSet ELISA Development System (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
In vivo treatment of mice with agonistic anti-CD30 Abs. Agonistic anti-CD30 mAbs (clone 30.1) were obtained as previously described. 26 The mAbs, diluted to 1 mg ml À 1 in phosphate-buffered saline, were stored at À 80 1C until use. For in vivo activation, 200 mg of agonistic anti-CD30 mAb or isotype control (hamster IgG1; BD Biosciences) was injected intraperitoneally into mice concomitantly with infection.
Statistical analysis. Statistical significance was calculated by Student's t-test using Prism software (GraphPad Software, La Jolla, CA). Differences with P-values of o0.05 were considered statistically significant.
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